Literature DB >> 7914355

Minimal-change glomerulopathy and glomerular visceral epithelial hyperplasia associated with alpha-interferon therapy for cutaneous T-cell lymphoma.

A Traynor1, T Kuzel, E Samuelson, Y Kanwar.   

Abstract

A 44-year-old man was diagnosed with cutaneous T-cell lymphoma characterized by a proliferation of CD4-positive cells. In response to alpha-interferon therapy, he experienced rapid regression of his cutaneous disease. This improvement was associated with development of renal failure, characterized by nephrotic-range proteinuria with interstitial nephritis and minimal-change nephropathy. The remarkable finding of renal biopsy was marked proliferation of visceral epithelial cells (podocytes). Renal disease improved significantly in response to discontinuation of interferon and initiation of prednisone therapy. Nephrotic range proteinuria regressed, but never completely resolved. This case is illustrative of the probable role for lymphokine-mediated nephrotoxicity in the setting of lymphoproliferative disease.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7914355     DOI: 10.1159/000187894

Source DB:  PubMed          Journal:  Nephron        ISSN: 1660-8151            Impact factor:   2.847


  4 in total

Review 1.  [Glomerulonephritis and malignant lymphoma. Mostly men with low-grade lymphoma with various forms of glomerulonephritis].

Authors:  J Zahner; D Bach; J Malms; W Schneider; K Diercks; B Grabensee
Journal:  Med Klin (Munich)       Date:  1997-12-15

2.  Treatment with IFN-{alpha}, -{beta}, or -{gamma} is associated with collapsing focal segmental glomerulosclerosis.

Authors:  Glen S Markowitz; Samih H Nasr; M Barry Stokes; Vivette D D'Agati
Journal:  Clin J Am Soc Nephrol       Date:  2010-03-04       Impact factor: 8.237

3.  An unexpected presentation: minimal change disease in an adult with treatment-naïve hepatitis C.

Authors:  Audrey L Stokes; Tarek Alhamad; Catherine S Abendroth; Hosam A Farag; Navin Verma
Journal:  Int Urol Nephrol       Date:  2012-09-22       Impact factor: 2.370

4.  Minimal Change Disease as a Secondary and Reversible Event of a Renal Transplant Case with Systemic Lupus Erythematosus.

Authors:  Elena Gkrouzman; Kyriakos A Kirou; Surya V Seshan; James M Chevalier
Journal:  Case Rep Nephrol       Date:  2015-08-13
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.